| 3.11 Data as of Jun 18 |  +0.11 / +3.67%Today’s Change | 1.75 Today|||52-Week Range 4.12 | +17.80% Year-to-Date |
| Previous close | 3.00 |
| Today’s open | 2.98 |
| Day’s range | -- - -- |
| Volume | 29,213 |
| Average volume (3 months) | 12,191 |
| Market cap | -- |
| Dividend yield | -- |
| Earnings growth (last year) | +44.78% |
| Earnings growth (this year) | +72.97% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -7.80% |
| P/E ratio | NM |
| Price/Sales | 35.16 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| DRRXDURECT Corp | +0.02 | +2.72% |
| IMMYImprimis Pharmaceuti... | +0.18 | +1.94% |
| APRIApricus Biosciences ... | -0.09 | -3.38% |
| ALXAAlexza Pharmaceutica... | -0.06 | -1.31% |
| Next reporting date | August 16, 2013 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $1.3M |
| Annual profit (last year) | -$13.1M |
| Net profit margin | -982.94% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director John N. Bonfiglio, PhD, MBA |
Chief Financial Officer, Secretary & Treasurer Michael O'Keefe Sullivan, MBA, CPA |
Corporate headquarters Tampa, Florida |
.
